Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Total Non-Current Liabilities: 2018-2021

  • Genmab A's Total Non-Current Liabilities rose 26.03% to $104.50 in Q2 2021 from the same period last year, while for Jun 2021 it was $104.50, marking a year-over-year increase of 26.03%. This contributed to the annual value of $58.4 million for FY2020, which is 2061.10% up from last year.
  • Per Genmab A's latest filing, its Total Non-Current Liabilities stood at $104.50 for Q2 2021, which was down 100.00% from $58.4 million recorded in Q4 2020.
  • Genmab A's 5-year Total Non-Current Liabilities high stood at $58.4 million for Q4 2020, and its period low was $82.91 during Q2 2020.
  • In the last 3 years, Genmab A's Total Non-Current Liabilities had a median value of $2.7 million in 2019 and averaged $15.7 million.
  • Within the past 5 years, the most significant YoY rise in Genmab A's Total Non-Current Liabilities was 2,061.10% (2020), while the steepest drop was 100.00% (2020).
  • Over the past 4 years, Genmab A's Total Non-Current Liabilities (Quarterly) stood at $363,751 in 2018, then surged by 643.33% to $2.7 million in 2019, then surged by 2,061.10% to $58.4 million in 2020, then increased by 26.03% to $104.50 in 2021.
  • Its Total Non-Current Liabilities was $104.50 in Q2 2021, compared to $58.4 million in Q4 2020 and $82.91 in Q2 2020.